AM-Pharma

AM-Pharma develops human alkaline phosphatase therapeutics for the treatment of acute kidney injury.

Business Model:

Revenue: $31.4M

Employees: 11-50

Detailed AM-Pharma Information

Geographic Data

AM-Pharma headquarters map

Address: Stadsplateau 6

City: Utrecht

State: utrecht

Zip: 3521

Country: NL

Financial Info

Stage:

debt financing

Raised Last:

$26M

Raised Total:

$242M

Metrics

6,367,703Website Global Rank

1,088Website Monthly Traffic

Twitter Followers

Description

AM-Pharma develops human alkaline phosphatase therapeutics for the treatment of acute kidney injury.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
8/2007 Series C 2 $3.4M Forbion Capital Partners
Inventages Venture Capital Investment Inc.
Forbion Capital Partners
Inventages Venture Capital Investment Inc.
9/2011 Series D 4 $39.9M Kurma Partners
Ysios Capital
Idinvest Partners
BB Biotech Ventures
Kurma Partners
Ysios Capital
9/2014 Series E 6 $15.8M Gilde Healthcare
Kurma Partners
AbbVie Biotech Ventures
BB Biotech Ventures
Inventages Venture Capital Investment Inc.
Ysios Capital
Gilde Healthcare
Kurma Partners
7/2019 Series F 8 $130.1M Andera Partners
Life Sciences Partners
Ysios Capital
Pureos Bioventures
Kurma Partners
Idinvest Partners
Gilde Healthcare
Forbion Capital Partners
Andera Partners
Life Sciences Partners
5/2015 Equity $87.5M Pfizer
8/2001 Series A 1 $569.5k Biopartners Capital
Biopartners Capital
3/2020 Venture Round 8 $25.4M Andera Partners
BB Biotech Ventures
Cowen Healthcare Investments
Forbion Capital Partners
Gilde Healthcare
Idinvest Partners
Kurma Partners
Ysios Capital
Andera Partners
BB Biotech Ventures
Cowen Healthcare Investments
Forbion Capital Partners
Gilde Healthcare
Idinvest Partners
Kurma Partners
Ysios Capital
8/2011 Venture Round 1 - Idinvest Partners
Idinvest Partners
3/2020 Debt Financing 1 $26.5M European Investment Bank
European Investment Bank
5/2015 Corporate Round 1 - Pfizer
Pfizer
7/2019 Series E $130.7M Andera Partners
LSP
Forbion
Ysios Capital
Kurma Partners
ID Invest Partners
BB Pureos Bioventures
Gilde Healthcare
2/2002 Series B 2 - ABN AMRO Fund
Biopartners Capital
ABN AMRO Fund
Biopartners Capital
9/2014 Series E $15.7M Gilde Healthcare Partners
AbbVie
BB Biotech Ventures
IDInvest Partners
Inventages
Ysios Capital
3/2020 Seed Round 1 - Eurazeo
Eurazeo
9/2011 Series D $39.8M Ysios Capital
Kurma Partners
BB Biotech Ventures
IDInvest Partners
3/2020 Seed Round 1 - Eurazeo
Eurazeo
5/2015 Corporate Round 1 -
8/2011 Venture Round 1 - Idinvest Partners
Idinvest Partners
2/2002 Series B 2 - ABN AMRO Fund
ABN AMRO Fund
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research